Multi-gene panel testing: what it catches beyond BRCA, and when it's worth requesting

BRCA1 and BRCA2 dominate public awareness of hereditary cancer risk, largely due to their well-established link to breast and ovarian cancer and extensive media coverage over the years. They're far from the only genes that meaningfully raise cancer risk when mutated, though — Lynch syndrome genes (associated with significantly elevated colorectal and endometrial cancer risk), along with ATM, CHEK2, PALB2, and several others, each carry their own distinct, sometimes substantial, cancer risk profiles, and modern genetic testing has moved from single-gene BRCA-only tests toward multi-gene panels that screen dozens of these genes simultaneously in a single test.

This shift matters clinically because relying on family history and clinical presentation alone to decide which single gene to test for often misses the actual answer — a patient with a strong family history of colorectal cancer might reasonably be tested only for Lynch syndrome genes under an older single-gene testing approach, when a broader panel might reveal a different or additional hereditary cancer gene entirely that a narrower test would have missed.

Each gene identified on a panel carries its own specific associated cancer risks, penetrance (how likely a mutation carrier actually is to develop cancer), and recommended management — meaning a positive result isn't a single uniform answer but a specific finding requiring genetic counselor interpretation to translate into an actual personalized screening and prevention plan, which might include earlier or more frequent screening, additional cancer types to monitor for, or in some cases risk-reducing surgery.

For anyone with a personal or family history suggestive of hereditary cancer risk — multiple relatives with the same or related cancers, cancer diagnosed at an unusually young age, or a specific ethnic background associated with higher hereditary cancer gene prevalence — requesting a broader multi-gene panel rather than assuming a negative BRCA-only test rules out hereditary risk is worth discussing directly with a genetic counselor, since BRCA is only one piece of a considerably larger picture.